Literature DB >> 15736017

Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.

Ying Shan1, Richard W Lambrecht, Herbert L Bonkovsky.   

Abstract

BACKGROUND: There is growing evidence that mildly increased amounts of iron in the liver can increase hepatic injury, particularly if combined with other hepatotoxic factors, such as alcohol use, use of porphyrogenic drugs, or chronic viral hepatitis. In the present study, the association of hepatitis C virus (HCV) infection with serum measurements of iron status was assessed in the US population.
METHODS: We analyzed data from a total of 14,462 participants in the Third National Health and Nutrition Examination Survey. We excluded subjects who were aged <12 years, subjects for whom measurements of serum levels of iron or ferritin or the results of liver function tests were missing, and subjects who had a serum transferrin saturation of > or =50% (to help exclude subjects with hemochromatosis).
RESULTS: Mean serum levels of ferritin and iron (+/- standard error) were significantly higher among subjects with HCV infection (100+/-3 ng/mL and 229+/-17 microg/dL, respectively) than among subjects without liver disease (83+/-0.3 ng/mL and 101+/-2.1 microg/dL, respectively) (P<.0001). Serum levels of ferritin were directly and significantly correlated with serum levels of alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transpeptidase (r=0.25, r=0.24, and r=0.28, respectively; P<.0001), whereas platelet counts were inversely correlated with serum levels of ferritin (r=-0.12; P<.0001).
CONCLUSION: HCV infection is significantly associated with higher serum levels of ferritin and iron in the US population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736017     DOI: 10.1086/428062

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Interaction between hepatitis C virus and metabolic factors.

Authors:  Yasunori Kawaguchi; Toshihiko Mizuta
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Prognostic factors associated with hepatitis C disease: a case-control study utilizing U.S. multiple-cause-of-death data.

Authors:  Matthew Wise; Lyn Finelli; Frank Sorvillo
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

3.  The iron homeostasis network and hepatitis C virus - a new challenge in the era of directly acting antivirals.

Authors:  Katarzyna Sikorska
Journal:  Virulence       Date:  2016-05-19       Impact factor: 5.882

4.  Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia.

Authors:  Maria Atta; Milena Cabral; Gilvan Santos; Raymundo Paraná; Ajax Atta
Journal:  Inflamm Res       Date:  2012-06-21       Impact factor: 4.575

Review 5.  Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

6.  Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy.

Authors:  Reza Boostani; Mina Khodabandeh; Seyyed Abdolrahim Rezaee; Houshang Rafatpanah; Sanaz Ahmadi Ghezeldasht; Zohreh Vahidi; Zahra Baghestani
Journal:  J Neurovirol       Date:  2021-04-20       Impact factor: 2.643

7.  Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.

Authors:  Sang Hyub Lee; Sook-Hyang Jeong; Young Soo Park; Jin-Hyeok Hwang; Jin-Wook Kim; Nayoung Kim; Dong Ho Lee
Journal:  Korean J Hepatol       Date:  2010-09

Review 8.  Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.

Authors:  Kívia Queiroz de Andrade; Fabiana Andréa Moura; John Marques dos Santos; Orlando Roberto Pimentel de Araújo; Juliana Célia de Farias Santos; Marília Oliveira Fonseca Goulart
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

Review 9.  Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities.

Authors:  Puiyan Lam; Fan Cheung; Hor Yue Tan; Ning Wang; Man Fung Yuen; Yibin Feng
Journal:  Int J Mol Sci       Date:  2016-03-29       Impact factor: 5.923

10.  Post-transfusion hepatitis C virus infection among β-thalassaemic individuals with associated clinical parameters.

Authors:  Aritra Biswas; Rushna Firdaus; Kallol Saha; Prosanto Chowdhury; Debyojyoti Bhattacharya; Maitreyee Bhattacharyya; Provash Chandra Sadhukhan
Journal:  Indian J Med Res       Date:  2018-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.